Join to View Full Profile
10 Center Dr Bldg 10 Rm.2c433Bethesda, MD 20892
Phone+1 301-219-9233
Dr. Remaley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Pittsburgh School of MedicineClass of 1987, MD
Certifications & Licensure
PA State Medical License 1990 - 2026
American Board of Pathology Clinical Pathology
Publications & Presentations
PubMed
- Commentary on Variants of Unknown Significance in Hyperlipidemia: A Diagnostic Quandary.Rafael Zubiran, Marcelo Amar, Alan T Remaley
The Journal of Applied Laboratory Medicine. 2025-04-22 - Cross-sectional evaluation of the metabolic vulnerability index in heart failure populations.Kayode O Kuku, Joseph J Shearer, Jungnam Joo, Alan T Remaley, Margery A Connelly
BMC Cardiovascular Disorders. 2025-04-17 - 1 citationsANGPTL3/8 is an atypical unfoldase that regulates intravascular lipolysis by catalyzing unfolding of lipoprotein lipase.Anni Kumari, Sanne W R Larsen, Signe Bondesen, Yuewei Qian, Hao D Tian
Proceedings of the National Academy of Sciences of the United States of America. 2025-03-25
Press Mentions
ADLM Publishes Guidance on Lipid Testing for Cardiovascular DiseaseSeptember 3rd, 2024- Remnant Cholesterol Improves CV Risk PredictionJune 20th, 2022
- Lipoprotein(a): What to Know About Elevated LevelsJanuary 19th, 2024
- Join now to see all
Grant Support
- Development and assessment of cardiovascular risk biomarkersNATIONAL HEART, LUNG, AND BLOOD INSTITUTEPresent
- Development of Apo Mimetic Peptides for the Treatment Cardiovascular DiseaseNATIONAL HEART, LUNG, AND BLOOD INSTITUTEPresent
- Development of Apo Mimetic Peptides for the Treatment Cardiovascular DiseaseNATIONAL HEART, LUNG, AND BLOOD INSTITUTEPresent
- Development and assessment of cardiovascular risk biomarkersNATIONAL HEART, LUNG, AND BLOOD INSTITUTEPresent
- Role of fatty acids in health and disease.NATIONAL HEART, LUNG, AND BLOOD INSTITUTEPresent
- Role of fatty acids in health and disease.NATIONAL HEART, LUNG, AND BLOOD INSTITUTEPresent
- Role of fatty acids in health and disease.NATIONAL HEART, LUNG, AND BLOOD INSTITUTEPresent
- Role of fatty acids in health and disease.NATIONAL HEART, LUNG, AND BLOOD INSTITUTEPresent
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
